Who is sponsoring NCT05349448?

NCT05349448 is sponsored by Minia University.

What drugs are being tested in NCT05349448?

Interventions in NCT05349448: Hylase plus Triamcinolone plus sterile isotonic saline, Hylase plus Dexmedetomidine plus Triamcinolone.

What condition does NCT05349448 study?

NCT05349448 studies Pain, Neuropathic.

Is NCT05349448 still recruiting?

NCT05349448 is currently status unknown. Last updated 22 June 2022.

Last reviewed 2022-06-22 · How we verify

NCT05349448

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Can Dexmedetomidine With Hyalase Augment Quality and Duration of Analgesia When Added to Lumbar Epidural Steroid in Failed Back Surgery. Randomized Double Blind Study

Status unknown EARLY_PHASE1 Last updated 22 June 2022

What this trial tests

EARLY_PHASE1 trial testing Hylase plus Triamcinolone plus sterile isotonic saline in Pain, Neuropathic in 100 participants. Status unknown.

Timeline

28 March 2022

Primary endpoint
20 November 2022

10 December 2022

Quick facts

Lead sponsor	Minia University
Phase	EARLY_PHASE1
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	100
Start date	28 March 2022
Primary completion	20 November 2022
Estimated completion	10 December 2022
Sites	1 location across Egypt

Drugs / interventions tested

Hylase plus Triamcinolone plus sterile isotonic saline — full drug profile →
Hylase plus Dexmedetomidine plus Triamcinolone — full drug profile →

Conditions studied

Pain, Neuropathic — all drugs for Pain, Neuropathic →

Sponsor

Minia University

Who can join

Adults 30 to 70, any sex, with Pain, Neuropathic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

use of dexmedtemodine to augment analgesia in cases of failed back surgery

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pain, Neuropathic

Currently open trials in the same condition.

NCT06443281 — Pain Phenotyping in Patients With Neuropathic Pain After Spinal Cord Injury · recruiting
NCT04299893 — Ozone Therapy in Chemotherapy-induced Peripheral Neuropathy: RCT (O3NPIQ) · Phase 2, PHASE3 · recruiting

Other Minia University trials

Trials by the same sponsor.

NCT07525687 — Temporary Uterine Tourniquet Application Versus Local Myometrial Epinephrine Injection During Laparoscopic Myomectomy · NA · not yet recruiting
NCT07525674 — Vacuum Sealing Drainage (VSD) in Promoting Wound Healing and Reducing Complications in Post-Infected Obstetric and Gynec · NA · not yet recruiting
NCT07529587 — Laparoscopic Umbilico-uterine Trunk Clipping Approach in the Management of Enhanced Myometrial Vascularity · NA · not yet recruiting
NCT07500558 — Ultrasound Guided Infratemporal Sphenopalatine Ganglion Supravoltage Versus Standard Voltage Pulsed Radiofrequency for P · NA · not yet recruiting
NCT07428057 — Postoperative Hypocalcemia After Thyroidectomy · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05349448 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Minia University
Last refreshed: 22 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05349448.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing